Synthesis and Biological Activity Assessment of Different Diastereomers in siRNA Drug LEQVIO (Inclisiran) (U01) Clinical Trial Not Allowed

Food and Drug Administration · Other Federal · FOR-FD-24-007

Source: Grants.gov · View original posting ↗

AwardWhat a single award can be worth — the funder's published per-award amount or floor–ceiling range.

Amount not listed

DeadlineFinal application due date.

Not yet posted

Letter of intentDue date for the letter of intent (a short pre-application some funders require or request before the full proposal).

—

MechanismNIH activity code — the grant type (R01 research project, R21 exploratory, K series career development, F series fellowship, …).

U01

DurationMaximum project period for a single award.

—

Expected awardsHow many awards the funder anticipates making under this opportunity.

—

Funding cycleHow often the program accepts applications (annual, multiple cycles per year, rolling, or one-time).

Unknown

Open dateWhen applications open (or opened).

Nov 24, 2023

Total fundingThe overall pool the funder expects to commit across ALL awards under this opportunity — not what one project receives.

—

Clinical trialWhether proposed projects must, may, or must not include a clinical trial.

Not allowed